FDA Approves First mRNA Flu Vaccine by Moderna

Source Summary

The FDA has approved Moderna's mRNA flu vaccine for adults aged 50 and older, marking the first mRNA-based flu vaccine approved in the United States. The approval covers two age groups: people 50 to 64 and those 65 years and older. Moderna will conduct a postmarket clinical trial to confirm the vaccine's effectiveness.